Peripheral Artery Disease
Peripheral Artery Disease (PAD) is a vascular disorder characterized by the narrowing of arteries, most commonly in the legs and feet, due to atherosclerosis, resulting in reduced blood flow to these areas. This condition affects arteries that carry blood away from the heart to other body parts, excluding those that supply the heart or brain.
Health Outcomes
- Achieved Clinically Significant Systolic Blood Pressure Reduction
- Changed Walking Cadence
- Delayed Cardiac Pathology
- Enhanced Folate Synthesis
- Enhanced Wound Healing
- Improved 20-m Linear Sprint Time
- Improved 6-Meter Walk Performance
- Improved 6-Minute Walk Test Distance
- Improved 6-minute Walking Distance
- Improved Aerobic Endurance Performance
- Improved Anaerobic Power
- Improved Anaerobic Threshold
- Improved Angiogenesis
- Improved Angiogenic Biomarker
- Improved Ankle-Brachial Index
- Improved Arginine to Asymmetric Dimethylarginine Ratio
- Improved Auto-Aggregation Capability
- Improved Blood Flow
- Improved Blood Vessel Growth
- Improved Brachial Artery Diameter
- Improved CVD-Related Symptom
- Improved Cardiovascular Disease Marker
- Improved Cardiovascular Disease Outcomes
- Improved Cardiovascular Function
- Improved Cardiovascular Health
- Improved Circulation
- Improved Combined Cardiopulmonary Outcomes
- Improved Critical Velocity
- Improved Cutaneous Blood Flow
- Improved Diabetic Foot Ulcer Healing
- Improved Distance Traveled
- Improved Endothelial Cell Migration
- Improved Endothelial Function
- Improved Endothelial Function Biomarker
- Improved Endothelial Health Marker Level
- Improved Endothelial Reactivity
- Improved Endothelium-Dependent Vasodilation
- Improved Endothelium-Independent Microvascular Vasodilation
- Improved Endurance Exercise Performance
- Improved Exercise Duration
- Improved Exercise Endurance
- Improved Exercise Function
- Improved Exercise Recovery
- Improved Exercise Test Performance
- Improved Exercise Time to Exhaustion
- Improved Exercise Tolerance
- Improved Exercise-Onset Vasodilator Kinetics
- Improved Fibrinolytic Activity
- Improved Flow-Mediated Dilatation
- Improved Flow-Mediated Dilation
- Improved Flow-Mediated Vasodilation
- Improved Functional Exercise Capacity
- Improved Intermittent Exercise Performance
- Improved Lactate Threshold
- Improved Leg Press Performance
- Improved Leg Ulcer Healing
- Improved Limited Distance Test Performance
- Improved Lower Limb Peak Power
- Improved Maximal Exercise Capacity
- Improved Maximal Oxygen Consumption
- Improved Maximal Walking Performance
- Improved Maximal Workload or Power Output
- Improved Mean Arterial Pressure
- Improved Microvascular Vasodilation
- Improved Microvascular Vasodilator Response
- Improved Muscle Oxygen Flux
- Improved Pain-Free Walking Distance
- Improved Passive Limb Movement Blood Flow
- Improved Peripheral Vascular Function
- Improved Physical Work Capacity
- Improved Reactive Hyperemia
- Improved Reactive Hyperemia Index
- Improved Run Time
- Improved Six Minute Walking Distance
- Improved Six-Minute Walk Distance
- Improved Six-Minute Walk Test
- Improved Skin Perfusion
- Improved Stress-Strain Index
- Improved Tactile Sensitivity
- Improved Thermal Sensation
- Improved Tissue Oxygen Saturation Index
- Improved Vascular Biomarker
- Improved Vascular Conductance
- Improved Vascular Function
- Improved Vascular Function in Offspring
- Improved Vascular Reactivity
- Improved Vascular Repair
- Improved Vasodilation
- Improved Walking Ability
- Improved Walking Distance
- Improved Walking Speed
- Increased 6-Minute Walk Test Distance
- Increased Angiogenesis
- Increased Arginine/ADMA Ratio
- Increased Blood Homocysteine Level
- Increased CD34+ Cell Recruitment
- Increased Complete Ulcer Healing Frequency
- Increased Endothelial Nitric Oxide Synthase Activity
- Increased Endothelial Progenitor Cell Count
- Increased Exercise Capacity
- Increased Hemodynamic Disturbance
- Increased L-Arginine to ADMA Ratio
- Increased Nitric Oxide Bioavailability
- Increased Peak Oxygen Uptake
- Increased Peak Systolic Velocity
- Increased Plasma Nitric Oxide Levels
- Increased Plasma Total Cysteine Concentration
- Increased Regenerating Fiber Count
- Increased Shear Force
- Increased Smoking Cessation Rate
- Increased Walking Speed
- Inhibited Platelet Aggregation
- Modulated Anterograde Blood Flow
- Modulated Anterograde Shear Rate
- Modulated Arterial Diameter
- Modulated Retrograde Blood Flow
- Modulated Retrograde Shear Rate
- No Change in Major Cardiovascular Event
- Prevented Vascular Calcification
- Reduced APO-B/A1 Ratio
- Reduced Anaerobic Lactic Energy
- Reduced Angiogenesis
- Reduced Aortic Superoxide Levels
- Reduced Apolipoprotein B-100 to Apolipoprotein A-1 Ratio
- Reduced Arterial Calcification Progression
- Reduced Arterial Calcification Score
- Reduced Arterial Stiffness
- Reduced Atherogenic Index
- Reduced Atherosclerosis Risk Factors
- Reduced Atherosclerotic Cardiovascular Disease Event
- Reduced Atherosclerotic Plaque Formation
- Reduced Cadence
- Reduced Cardiovascular Disease Incidence
- Reduced Cardiovascular Disease Symptom
- Reduced Cardiovascular Dysfunction
- Reduced Cardiovascular Event
- Reduced Cardiovascular Event Rate
- Reduced Cardiovascular Event Risk
- Reduced Cardiovascular Mortality
- Reduced Central Blood Pressure
- Reduced Contrast-Induced Acute Kidney Injury
- Reduced Debridement Time
- Reduced Desphosphorylated-Uncarboxylated Matrix Gla Protein Level
- Reduced Flow-Mediated Dilation
- Reduced Forearm Blood Flow Response to Acetylcholine
- Reduced Forward Wave Amplitude
- Reduced Forward Wave Pressure
- Reduced HDL Cholesterol
- Reduced HMG-CoA Reductase Inhibition
- Reduced Hyperlipidemia
- Reduced Incidence of Footpad Lesions
- Reduced Intimal Thickening
- Reduced LDL Aggregation
- Reduced Leg Adiposity
- Reduced Leg Pain
- Reduced Matrix Gla Protein Level
- Reduced Monocyte Adhesion
- Reduced Muscle Deoxygenation Rate
- Reduced Plaque
- Reduced Platelet Aggregation
- Reduced Platelet Aggregation Rate
- Reduced Platelet Function Marker Level
- Reduced Platelet Hyperactivation
- Reduced Pressure Injury Occurrence
- Reduced Skin Sensitivity
- Reduced Sprint Time
- Reduced Statin Discontinuation Rate
- Reduced TXB2 Level
- Reduced Thermal Sensation
- Reduced Thrombosis
- Reduced Thromboxane A2 Level
- Reduced Time Trial Completion Time
- Reduced Time to Complete Uphill Time Trial
- Reduced Triacylglycerol-Rich Lipoprotein Cholesterol Level
- Reduced Ulcer Healing Time
- Reduced Ulcer Size
- Reduced Vascular Calcification
- Reduced Vascular Calcification Biomarker Level
- Reduced Vascular Calcification Progression
- Reduced Vascular Cell Adhesion Molecule-1 Level
- Reduced Vascular Damage
- Reduced Vascular Endothelial Growth Factor Level
- Reduced Vascular Restenosis
- Reduced Walking Time
- Reduced Wound Area
- Reduced Wound Healing Time